
### [MONDO:0015901](http://purl.obolibrary.org/obo/MONDO_0015901)
**Label:** rare hyperlipidemia

**Subclasses:** [MONDO:0018328](http://purl.obolibrary.org/obo/MONDO_0018328) (homozygous familial hypercholesterolemia), [MONDO:0007744](http://purl.obolibrary.org/obo/MONDO_0007744) (cholesterol-ester transfer protein deficiency), [MONDO:0018799](http://purl.obolibrary.org/obo/MONDO_0018799) (rare hypercholesterolemia), [MONDO:0019247](http://purl.obolibrary.org/obo/MONDO_0019247) (combined hyperlipidemia), [MONDO:0015903](http://purl.obolibrary.org/obo/MONDO_0015903) (hyperalphalipoproteinemia), [MONDO:0015902](http://purl.obolibrary.org/obo/MONDO_0015902) (major hypertriglyceridemia), [MONDO:0018637](http://purl.obolibrary.org/obo/MONDO_0018637) (familial chylomicronemia syndrome), 

**Corr. equiv. classes:** [Orphanet:477811](http://www.orpha.net/ORDO/Orphanet_477811), [Orphanet:181428](http://www.orpha.net/ORDO/Orphanet_181428), [Orphanet:391665](http://www.orpha.net/ORDO/Orphanet_391665), [Orphanet:181425](http://www.orpha.net/ORDO/Orphanet_181425), [Orphanet:79506](http://www.orpha.net/ORDO/Orphanet_79506), [OMIM:602247](http://purl.obolibrary.org/obo/OMIM_602247), [Orphanet:444490](http://www.orpha.net/ORDO/Orphanet_444490), [OMIM:118830](http://purl.obolibrary.org/obo/OMIM_118830), [OMIM:603813](http://purl.obolibrary.org/obo/OMIM_603813), [OMIM:143890](http://purl.obolibrary.org/obo/OMIM_143890), [OMIM:207750](http://purl.obolibrary.org/obo/OMIM_207750), [OMIM:143470](http://purl.obolibrary.org/obo/OMIM_143470), [OMIM:614028](http://purl.obolibrary.org/obo/OMIM_614028), [OMIM:615947](http://purl.obolibrary.org/obo/OMIM_615947), [OMIM:238600](http://purl.obolibrary.org/obo/OMIM_238600), [Orphanet:79211](http://www.orpha.net/ORDO/Orphanet_79211), 

**Class expressions from DL-Learner:**

- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0003141](http://purl.obolibrary.org/obo/HP_0003141) (Increased circulating low-density lipoprotein levels))) 71.88%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0010981](http://purl.obolibrary.org/obo/HP_0010981) (Hypolipoproteinemia))) 69.72%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels))) 69.72%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier))) 67.64%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0012144](http://purl.obolibrary.org/obo/HP_0012144) (Abnormality of cells of the monocyte/macrophage lineage))) 67.64%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0011492](http://purl.obolibrary.org/obo/HP_0011492) (Abnormality of corneal stroma))) 67.64%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system))) 67.64%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0010974](http://purl.obolibrary.org/obo/HP_0010974) (Abnormality of myeloid leukocytes))) 67.64%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0010876](http://purl.obolibrary.org/obo/HP_0010876) (Abnormality of circulating protein level))) 67.64%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0007957](http://purl.obolibrary.org/obo/HP_0007957) (Corneal opacity))) 67.64%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0007759](http://purl.obolibrary.org/obo/HP_0007759) (Opacification of the corneal stroma))) 67.64%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0005561](http://purl.obolibrary.org/obo/HP_0005561) (Abnormality of bone marrow cell morphology))) 67.64%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe))) 67.64%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0004311](http://purl.obolibrary.org/obo/HP_0004311) (Abnormality of macrophages))) 67.64%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature))) 67.64%


